NV
Founded in 2018, Northpond Ventures backs breakthrough science and technology ventures across biotechnology, therapeutics, diagnostics and digital health, with offices in Bethesda, Cambridge and San Francisco.
Carbon Silicon Ventures
Venture capital firm founded in 2022 backing founders building companies at the intersection of biology and engineering, across biotech, drug discovery and healthcare.
Carbon Silicon Ventures is a venture capital firm founded in 2022 that invests in companies at the intersection of biology and engineering. Its stated thesis is that biology is becoming an engineering discipline, and it backs founders bringing engineering rigour, scalability and new capabilities to biotechnology, life-science workflows, healthcare and drug discovery. The firm operates from the United States.
Portfolio composition reflects that focus. Thirteen companies are publicly listed among its investments: Ansa Biotechnologies, Octant, Basepair, Medra AI, Femtofluidics, Sphinx Bio, Olden Labs, Bluenote Health, Current Surgical, BUILT DNA, Paralos Bio, Tomorrow Taste and Odola Labs. The names span tools and platforms, drug discovery, healthcare delivery and applied biology, suggesting an approach oriented to the enabling layers of the sector rather than a single therapeutic category.
The firm states that it looks for strong founding teams, scalable business models and the potential for societal impact. Nish Bhat is a cofounder and general partner. Fund size, check size and stage are not disclosed publicly; enquiries go to hello@carbonsilicon.vc.
Open jobs
No open jobs right now.